Sanofi and GlaxoSmithKline Snag Biggest Coronavirus Vaccine Deal Yet
The arrangement brings the Trump administration ’s investment in coronavirus vaccine projects to more than $8 billion. The head of the federal effort is a former GSK executive.
Source: NYT Health - Category: Consumer Health News Authors: Katie Thomas Tags: your-feed-science Vaccination and Immunization Conflicts of Interest Public-Private Sector Cooperation Coronavirus (2019-nCoV) Politics and Government GlaxoSmithKline PLC Sanofi SA Source Type: news
More News: American Health | Coronavirus | COVID-19 | Government | Health | Politics | Science | Trump | USA Health | Vaccines